Eikon Therapeutics, Inc.
EIKN
$12.31
$0.786.77%
NASDAQ
| 12/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 335.98M | 220.11M | |||
| Total Receivables | -- | -- | |||
| Inventory | -- | -- | |||
| Prepaid Expenses | 12.54M | 7.38M | |||
| Finance Division Loans and Leases Current | -- | -- | |||
| Total Finance Division Other Current Assets | -- | -- | |||
| Other Current Assets | 400.00K | 400.00K | |||
| Total Current Assets | 348.92M | 227.89M | |||
|
|
|||||
| Total Current Assets | 348.92M | 227.89M | |||
| Net Property, Plant & Equipment | 233.86M | 259.13M | |||
| Long-term Investments | -- | -- | |||
| Goodwill | -- | -- | |||
| Total Other Intangibles | -- | -- | |||
| Finance Div Loans & Leases LT | -- | -- | |||
| Total Finance Div Other LT Assets | -- | -- | |||
| Total Other Assets | 11.95M | 4.22M | |||
| Total Assets | 594.73M | 491.24M | |||
|
|
|||||
| Total Accounts Payable | 681.00K | 17.58M | |||
| Total Accrued Expenses | 44.16M | 29.16M | |||
| Short-term Debt | -- | -- | |||
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | |||
| Finance Division Debt Current | 10.03M | 9.31M | |||
| Total Finance Division Other Current Liabilities | 137.00K | 404.00K | |||
| Total Other Current Liabilities | 137.00K | 404.00K | |||
| Total Current Liabilities | 55.01M | 56.45M | |||
|
|
|||||
| Total Current Liabilities | 55.01M | 56.45M | |||
| Long-Term Debt | -- | -- | |||
| Short-term Debt | -- | -- | |||
| Capital Leases | 247.29M | 193.15M | |||
| Finance Division Debt Non Current | -- | -- | |||
| Total Finance Division Other Non Current Liabilities | -- | -- | |||
| Total Other Liabilities | 10.00M | 5.35M | |||
| Total Liabilities | 312.30M | 254.95M | |||
|
|
|||||
| Common Stock & APIC | 41.48M | 33.01M | |||
| Retained Earnings | -920.51M | -604.94M | |||
| Treasury Stock & Other | -- | -- | |||
| Total Common Equity | -879.03M | -571.93M | |||
|
|
|||||
| Preferred Stock Redeemable | -- | -- | |||
| Preferred Stock Non Redeemable | -- | -- | |||
| Preferred Stock Convertible | 1.16B | 808.22M | |||
| Preferred Stock, Others | -- | -- | |||
| Total Preferred Equity | 1.16B | 808.22M | |||
|
|
|||||
| Total Common Equity | -879.03M | -571.93M | |||
| Total Preferred Equity | 1.16B | 808.22M | |||
| Total Minority Interest | -- | -- | |||
| Total Equity | 282.44M | 236.29M | |||
|
|
|||||